Abstract
Eph receptors and their ephrin ligands were identified in the late 1980's. Subsequently, they were linked to different physiological and pathophysiological processes like embryonic development, angiogenesis, and tumorigenesis. In this regard, recent work focused on the distribution and effects of Eph receptors and ephrins on tumor cells and tumor microenvironment. The purpose of this review is to outline the role of these molecules in physiological angiogenesis and pathophysiological tumor angiogenesis. Furthermore, novel therapeutical approaches are discussed as Eph receptors and ephrins represent attractive targets for antiangiogenic therapy. © 2010 Birgit Mosch et al.
Cite
CITATION STYLE
Mosch, B., Reissenweber, B., Neuber, C., & Pietzsch, J. (2010). Eph receptors and ephrin ligands: Important players in angiogenesis and tumor angiogenesis. Journal of Oncology. https://doi.org/10.1155/2010/135285
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.